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One for a boy, two for a girl?
Sex determination in flies relies on the different ratio of X chromosomes
to autosomes in XX females and XY males. Mammals have a male-
determining Y-linked gene, but may retain dosage-related elements.
The existence of two sexes is a general theme in animal
biology. It might be expected that this commonality
would be reflected in conservation of the genetic mecha-
nisms that control whether an individual develops as a
male or a female. Unfortunately, this expectation has
been confounded by comparison of the chromosomal
sex-determination mechanisms of Caenorhabditis elegans,
Drosophila melanogaster and mammals. C. elegans and
Drosophila both depend on dosage of the X chromosome
for the primary sex-determining signal, but the way the
signal is propagated in the sex-determination pathway
differs between the two: worms use a genetic control
pathway that is regulated at the level of transcription,
whereas the fruitfly pathway is regulated post-
transcriptionally, by modification of splicing patterns.
For many years, it was assumed that humans and other
mammals also use dosage of the X chromosome for sex
determination. This assumption was dispelled by cytoge-
netic analyses of individuals with unusual sex-chromo-
some constitutions. Normal females have two X
chromosomes and normal males an X and a Y chromo-
some. But individuals with a single X chromosome and
no Y chromosome are female, whereas those with multi-
ple X chromosomes and a single Y develop as males.
Mammals therefore have a dominant Y chromosome that
is needed for male sex determination. In the past three
decades, a major emphasis of research in mammalian sex
determination has been the identification of the inducer
of male differentiation that is on the Y chromosome. But
a recent series of papers have raised the possibility that
remnants of a dosage-dependent sex-determination
mechanism are still present in mammals.
Sex determination in flies and worms
Female and male Drosophila have the same sex chromo-
some genotypes as female and male mammals - XX and
XY, respectively. The primary signal for sex determina-
tion in flies is the ratio of the number of X chromosomes
to the number of sets of autosomes - the X:A ratio [1,2].
Hence, in females, the X:A ratio is 1, and in males it is 2½.
The Y chromosome is needed for fertility of the male fly
but is irrelevant for male sex determination. The protein
encoded by the autosomal deadpan (dpn) gene, in con-
junction with a maternally provided gene product, extra-
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macrochaete (emc), titrates the gene product of the X-linked
gene, sisterless (sis) by the formation of heterodimers.
The limiting factor in these interactions is the amount of
Sis protein present, as both XX and XY organisms have
equal amounts of Dpn and Emc. Males, which have only
one X chromosome, have too little free Sis protein to
bind all the available Dpn and Emc; Sis also binds to the
product of another maternally provided gene, daughterless
(da). Females have enough Sis protein to allow them to
accumulate sufficient Da-Sis heterodimers to go on and
initiate activation of the sex-determining gene, Sex lethal
(Sxl) from its early promoter. Active 'early' Sxl protein,
which is present only in females, initiates the production
of active 'late' Sxl proteins from a different promoter
within the sxl gene. The presence or absence of the late
Sxl protein directs the course of a cascade of sex-specific
splicing interactions, which result in the production of
female or male morphogens, respectively.
Thus, sxl is central to the initial sex-determining steps of
sexually dimorphic development in the fly. But there is a
potential problem that arises as a result of the very differ-
ent genetic content of the fruitfly sex chromosomes -
the Y chromosome being almost bereft of genes - and
that is the problem of differential dosage of X-linked
genes between males and females later in development.
This has been solved by a two-fold increase in the
expression of X-linked genes in males, so that they
receive as much of each gene product as females do. This
dosage compensation, like initial sex determination, is
controlled by Sxl.
The male genotype in C. elegans is XO, with XX animals
being hermaphrodite. As in Drosophila, the X:A ratio reg-
ulates both sex determination and dosage compensation.
In XO animals, in response to the X:A ratio of ½, the
xol-1 gene product is produced, and this protein nega-
tively regulates sex-linked genes that are essential for
female differentiation and dosage compensation. Unlike
dosage-compensation in Drosophila, in which expression
from the male X chromosome is up-regulated, in
C. elegans there is a reduction in the level of expression
from the two X chromosomes in XX animals.
Mammalian sex determination
Jost and colleagues [3] showed, by transplantation exper-
iments, that the central event in mammalian male sex
determination is the induction and formation of testes
- instead of ovaries - from the embryonic genital
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ridge during fetal development. The testis-inducing, and
therefore male-determining, factor was named TDF
(testis-determining factor). In 1990, the SRY (sex-deter-
mining region of Y) gene was cloned from the short arm
of the Y chromosome [4], and it has now been proven
that SRY is the TDF. Mutations in the SRY open read-
ing frame are found in 'sex-reversed' XY female patients,
who are female despite having an apparently male chro-
mosome complement [5,6], and XX mice given a trans-
genic copy of the murine Sry gene develop as males [7].
The strict temporal and spatial regulation of SRY expres-
sion suggests that there are genes upstream that regulate
its expression. Furthermore, the DNA-binding proper-
ties of the SRY protein suggest that it regulates elements
further down the sex-determination pathway. In terms
of the dosage-compensation problem, the mammalian
chromosome shares very few genes with the X chromo-
some, and mammals have evolved a dosage-compen-
sation system whereby one X chromosome is largely
transcriptionally inactivated in each female cell [8].
A link between dosage and sex determination in mammals
In 1980, Bernstein and colleagues [9] described two sex-
reversed sisters who had inherited an apparently normal
Y chromosome and an X chromosome with an inter-
stitial duplication of part of the short arm of the X
chromosome. Several similar patients were subsequently
described. As the duplications were overlapping, but did
not have a common breakpoint, these results suggested
the presence of a gene on the X chromosome - named
DSS, for dosage-sensitive sex-reversal - that when pres-
ent in two active copies can override the effect of the Y
chromosome. In XXY individuals, this gene would be
subject to X-inactivation, allowing male development.
The screening of sex-reversed XY females who do not
have cytological abnormalities, using markers from the
short arm of the X chromosome, identified submicro-
scopic duplications, and these allowed refinement of the
position of DSS to a 160-kilobase stretch within the
Xp21 region [10]. Fortuitously, this region of the genome
had previously been cloned for the study of a syndrome
that involves contiguous genes and is manifest as adrenal
hypoplasia congenita (AHC), glycerol kinase deficiency
and Duchenne muscular dystrophy. As part of the search
for genes, the region was analyzed for so-called CpG
islands, motifs that are characteristic of transcribed regions
of the genome. A single CpG-rich region was found
within the 160-kilobase DSS region, and adjacent
sequences, which showed evolutionary conservation,
were used to isolate cDNA clones from adult human testis
and fetal adrenal libraries. The cDNA clones revealed a
previously unknown gene that encodes a novel member
of the nuclear hormone-receptor superfamily. Point
mutations in the gene were found in patients with AHC,
and the gene was named DAX-1 (the first gene in the
DSS-AHC-critical region of the X chromosome) [11].
AHC is a developmental disease in which the adre-
nals fail to form properly. The close embryological
Fig. 1. The influence of the DSS gene on sexual phenotype (see
text for details).
relationship between adrenals and gonads, and their
shared steroidogenic properties, support the hypothesis
that DAX- 1 might be both the DSS gene and responsible
for AHC. However, mutations in DAX- I1 that cause
adrenal hypoplasia do not affect testis development, and
Zanaria and colleagues [11] have failed to find mutations
of DAX-1 in a preliminary screen of 30 XY females.
There is a good chance that DAX- 1 is not the only gene
in the DSS region. A region of 160 kilobases would
be expected to contain (on average) three to five genes,
and 60 % of all genes - but only 40% of tissue-specific
genes - contain CpG islands [12], so there is a possi-
bility that other genes would have been missed by the
CpG-screening strategy.
Despite the uncertainty about whether DAX1 is indeed
the DSS gene, it is still possible to deduce some of the
remarkable properties of DSS. Large deletions that com-
pletely remove the DSS-AHC-critical region are com-
patible with testis development, so DSS must not be
needed in males, but two active copies result in ovarian
development in XY individuals (Fig. 1). One obvious
possibility is that DSS is required for ovarian develop-
ment and must be repressed in order to allow testes to
form. This model predicts that XX patients without DSS
would fail to form ovaries.
If SRY has overridden an ancestral dosage mechanism of
sex determination to become the sole TDF we would
expect that the original key sex-determining gene was
X-linked. A plausible scenario is that DSS interacted in a
dose-dependent fashion with an SRY-related gene, and
that SRY captured the sex-determination pathway at this
point. Eventually, X inactivation obscured any lingering
sex-determining properties of DSS. This view might
explain the rapid evolution of SRY, and leads to the
prediction that dosage-dependent SRY-related genes may
be still present in the mammalian sex-determination
DISPATCH 39
pathway. The discovery of a dosage-dependent element
in the mammalian pathway suggests similarities with the
fly and worm, but the remaining differences between the
three best-studied systems of sex determination are still
many and varied.
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